Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Therapy”

1,236 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,236 results

Testing effectiveness (Phase 2)Study completedNCT01936532
What this trial is testing

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Who this might be right for
Newly Diagnosed Multiple Myeloma
Nantes University Hospital 42
Testing effectiveness (Phase 2)UnknownNCT03805399
What this trial is testing

FUSCC Refractory TNBC Umbrella (FUTURE)

Who this might be right for
Triple-negative Breast Cancer
Fudan University 140
Not applicableStudy completedNCT03352206
What this trial is testing

Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

Who this might be right for
Lymphatic Filariases
Washington University School of Medicine 20,092
Large-scale testing (Phase 3)Looking for participantsNCT05862064
What this trial is testing

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 606
Testing effectiveness (Phase 2)Study completedNCT02422498
What this trial is testing

Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy

Who this might be right for
Locally Recurrent/Metastatic Triple Negative Breast Cancer
Memorial Sloan Kettering Cancer Center 49
Not applicableStudy completedNCT04879992
What this trial is testing

Rifabutin-containing Triple Therapy for Treatment of Helicobacter Pylori

Who this might be right for
Helicobacter Pylori Infection
Shanghai Jiao Tong University School of Medicine 413
Testing effectiveness (Phase 2)UnknownNCT03961698
What this trial is testing

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma

Who this might be right for
Breast CancerRenal Cell Carcinoma
Infinity Pharmaceuticals, Inc. 91
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339176
What this trial is testing

Intratumoral N17350 in Advanced Solid Tumors

Who this might be right for
Neoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more
Onchilles Pharma Inc 275
Large-scale testing (Phase 3)UnknownNCT01672216
What this trial is testing

Multicenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic Obstipation

Who this might be right for
Chronic Obstipation
dr. schwandner 140
Testing effectiveness (Phase 2)Study completedNCT05316818
What this trial is testing

Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Kasr El Aini Hospital 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05806385
What this trial is testing

Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers

Who this might be right for
Triple Negative Breast Cancer
Texas Tech University Health Sciences Center 36
Not applicableEnrolling By InvitationNCT05773950
What this trial is testing

Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant As PONV Prevention

Who this might be right for
Postoperative Nausea and VomitingGynecologic Surgical ProceduresLaparoscopy
Samsung Medical Center 144
Testing effectiveness (Phase 2)Looking for participantsNCT04648280
What this trial is testing

Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Who this might be right for
HIV Infections With Multi Drug Resistant Virus
PENTA Foundation 60
Testing effectiveness (Phase 2)Ended earlyNCT05219578
What this trial is testing

RTX-224 Monotherapy in Patients With Solid Tumors

Who this might be right for
Non Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more
Rubius Therapeutics 7
Large-scale testing (Phase 3)UnknownNCT00197418
What this trial is testing

Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection

Who this might be right for
Helicobacter InfectionsGastritisGastric Ulcer+1 more
Hamamatsu University
Post-approval studies (Phase 4)WithdrawnNCT01770223
What this trial is testing

Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT00516126
What this trial is testing

Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery

Who this might be right for
Coronary Artery Bypass Graft Triple VesselBlood Coagulation Disorders
University Hospital, Basel, Switzerland 200
Large-scale testing (Phase 3)Looking for participantsNCT06393374
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Who this might be right for
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC 1,530
Early research (Phase 1)WithdrawnNCT01333423
What this trial is testing

Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT06889688
What this trial is testing

Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer

Who this might be right for
Breast Cancer Stage IV
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 246
Load More Results